Viewing Study NCT06539195


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2025-12-27 @ 9:56 PM
Study NCT ID: NCT06539195
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2024-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)
Sponsor: Dizal Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module